We found that patients’ samples tend to be contaminated with different cell types even after CD45 depletion, but were able to use a mass-based filter to computationally increase the percentage of tumor cells evaluated and gauge a tumor cell response in mixed cultures. The gene discussed is PTPRC; the disease is neoplasm.